Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABT
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Abbott Laboratories (ABT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Abbott Laboratories (ABT) trades at $98.17, down 1.93% on the day, with a bearish technical signal despite strong analyst support. The company maintains solid fundamentals with $44.33B in 2025 revenue, 11.65% net income margin, and consistent dividend payments. Recent FDA approval for the TactiFlex Duo ablation catheter and institutional buying activity provide positive catalysts, though the stock faces headwinds from technical indicators and a recent $384M legal settlement related to infant formula issues.
ABT presents a compelling long-term investment case with 78.6% analyst buy ratings and a $119.91 consensus price target representing 22% upside. The company's strong profitability metrics and dividend king status are offset by near-term technical weakness and regulatory risks. Investors should weigh the attractive valuation against ongoing legal challenges and market volatility.
Read full analysis

Key Stats

  • Market Cap
    $170.84B
  • Volume
    9,031,212
  • Sector
    Health
  • 52W High
    $134.27
  • 52W Low
    $82.57
  • Typical Hold Time
    96 Days
  • Enterprise Value
    $197.85B
  • Div Yield
    2.55%
  • Trading Activity
    0% Sell | 100% Buy
$97.35
52W Low: $82.57
11 May 2026
52W High: $134.27
08 Oct 2025

Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $134.27, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Most Recent News

Content is generated by Aura AI

Resilinc launches Microsoft Copilot plugin for real-time, organization-specific supply chain risk and compliance insights.

Resilinc introduced a new plugin for Microsoft Copilot that allows authorized enterprise users to access live, organization-specific supply chain risk and compliance intelligence directly within Microsoft applications. This integration helps teams qu...

Market News
33 minutes ago
Not Specified
Bullish
news icon
Resilinc launches Microsoft Copilot plugin for real-time, organization-specific supply chain risk and compliance insights.

AI boosts lithium battery industry efficiency and investment across mining, manufacturing, and recycling sectors.

AI is transforming the lithium battery value chain by speeding up development, improving manufacturing yields, optimizing resource recovery, and enabling smarter recycling. Significant investments are flowing into AI-driven projects, including $2.2 b...

Market News
48 minutes ago
Bcc Research
Bullish
news icon
AI boosts lithium battery industry efficiency and investment across mining, manufacturing, and recycling sectors.

Global Mivan construction market to grow to $7.05B by 2031, driven by mass housing and automation.

The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...

Market News
1 hour ago
Researchandmarkets.Com
Bullish
news icon
Global Mivan construction market to grow to $7.05B by 2031, driven by mass housing and automation.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $170.84B
  • Volume
    9,031,212
  • Sector
    Health
  • 52W High
    $134.27
  • 52W Low
    $82.57
  • Typical Hold Time
    96 Days
  • Enterprise Value
    $197.85B
  • Div Yield
    2.55%
  • Trading Activity
    0% Sell | 100% Buy
$97.35
52W Low: $82.57
11 May 2026
52W High: $134.27
08 Oct 2025

Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $134.27, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!